Hospital Mater Dei S.A. (BVMF:MATD3)
4.830
+0.120 (2.55%)
Last updated: Jun 24, 2026, 4:32 PM GMT-3
Hospital Mater Dei Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Hospital Mater Dei stock has a consensus rating of "Buy" and an average price target of R$7.13. The average 1-year stock price forecast is 47.62% higher than the current stock price, while the lowest is R$6.30 (+30.43%) and the highest is R$8.00 (+65.63%).
Price Target: R$7.13 (+47.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Hospital Mater Dei stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
2.42B
from 2.18B
Increased by 11.43%
Revenue Next Year
2.65B
from 2.42B
Increased by 9.18%
EPS This Year
0.53
from 0.33
Increased by 60.61%
EPS Next Year
0.73
from 0.53
Increased by 37.02%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BRL.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.4B | ||
| Avg | 2.4B | ||
| Low | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.0% | ||
| Avg | 11.4% | ||
| Low | 10.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.53 | ||
| Avg | 0.53 | ||
| Low | 0.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 60.6% | ||
| Avg | 60.6% | ||
| Low | 60.6% |